Pharmafile Logo

Kath Kerry

- PMLiVE

Ipsen searches for new CEO after splitting top roles

Structural reshuffle aimed at accelerating international development

- PMLiVE

Wave Healthcare makes five new appointments

Boosts its programmes and editorial teams

- PMLiVE

Oral biologics delivery still elusive

The search for a better delivery method for peptide, protein and antibody drugs

- PMLiVE

Truly, madly, cheaply

The ongoing rhetoric of patient-centricity

Acting at random

Life science companies stumble through evolutionary space and often fall

- PMLiVE

Avoiding an Authenticity Gap in healthcare communications

Successful companies align their brand with their reputation

- PMLiVE

The big picture

Cost talks should go hand-in-hand with value discussions

Heart failure therapy embarks on a new era

After years of older, generic drugs, now new treatments are showing promising results

- PMLiVE

Challenging perceptions

Alvaro Herreros on the ADHD landscape

Not as we know it

We shouldn’t expect our descendants to look like us

- PMLiVE

Amgen’s roll-out of myeloma drug Kyprolis reaches UK

Company hopes to gain NICE approval later this year

- PMLiVE

Researchers say ‘neurostatins’ may ward off Alzheimer’s

Preclinical studies show bexarotene prevents nerve cell degeneration

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links